MUTUAL FUND: Invenomic Fund-Invenomic Fund Institutional Class (BIVIX)

Information as of 2020-10-31

LEI: 549300WBCPRL59QG8F92

Series ID: S000057713

631-470-2600
225 Pictoria Drive
Suite 450
Cincinnati, US-OH 45246

https://www.ultimusfundsolutions.com/

Taken from NPORT-P filing for 2021-01-31
Total Assets
327.73 Million
Total Liabilities
156.469 Million
Net Assets
171.261 Million
Month 1 NAV Shares Sold
7.376 Million
Month 1 NAV Shares Reinvested
0
Month 1 NAV Shares Redeemed
-4.108 Million
Related Share Classes:

Invenomic Fund-Invenomic Fund Super Institutional Class: BIVSX

Invenomic Fund-Invenomic Fund Institutional Class: BIVIX

Invenomic Fund-Invenomic Fund Investor Class: BIVRX

F/M Investments European L/S Small Cap Fund-F/M Investments European L/S Small Cap Fund Investor Class: BESRX

F/M Investments European L/S Small Cap Fund-F/M Investments European L/S Small Cap Fund Institutional Class: BESMX

Refresh Download CSV Download Excel (.xlsx) Download TSV

Funds Holding BIVIX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"
N-CEN Filings
Period of Report Filing Date View SEC Link
2020-10-31 2021-01-13 05:52:14 -0500 View Filing Original SEC Filing
2019-10-31 2020-01-14 04:16:04 -0500 View Filing Original SEC Filing
2018-10-31 2019-01-07 10:03:28 -0500 View Filing Original SEC Filing
N-PORT Filings
Period of Report Filing Date View SEC Link
Information Date: 2021-01-31
Fiscal Year End: 2021-10-31
2021-03-31 06:15:29 -0400 View Filing Original SEC Filing
Information Date: 2020-10-31
Fiscal Year End: 2020-10-31
2020-12-23 07:13:37 -0500 View Filing Original SEC Filing
Information Date: 2020-07-31
Fiscal Year End: 2020-10-31
2020-09-28 09:22:12 -0400 View Filing Original SEC Filing

Elevate your investments